The Heart Protection Study and bias in the interpretation of RCTs
2005; Wiley; Volume: 11; Issue: 4 Linguagem: Inglês
10.1111/j.1365-2753.2005.00508.x
ISSN1365-2753
AutoresPhilipp Conradi, David Taylor,
Tópico(s)Lipoproteins and Cardiovascular Health
ResumoJournal of Evaluation in Clinical PracticeVolume 11, Issue 4 p. 405-407 The Heart Protection Study and bias in the interpretation of RCTs Philipp Conradi MB BS, Corresponding Author Philipp Conradi MB BS GP in Nechells and Northfield, Birmingham, UKDr. Philipp Conradi, Otto-Dix-Ring 98, 01219 Dresden, Germany E-mail: [email protected]Search for more papers by this authorDavid Taylor MB BS, David Taylor MB BS GP in Nechells and Northfield, Birmingham, UKSearch for more papers by this author Philipp Conradi MB BS, Corresponding Author Philipp Conradi MB BS GP in Nechells and Northfield, Birmingham, UKDr. Philipp Conradi, Otto-Dix-Ring 98, 01219 Dresden, Germany E-mail: [email protected]Search for more papers by this authorDavid Taylor MB BS, David Taylor MB BS GP in Nechells and Northfield, Birmingham, UKSearch for more papers by this author First published: 11 July 2005 https://doi.org/10.1111/j.1365-2753.2005.00508.xRead the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References Heart Protection Study (2002) Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with Simvastatin I 20, 536 high risk individuals: a randomised placebo controlled trail. Lancet 360, 7– 22. Jenkins A. (2003) Might money spent on statins be better spent. British Medical Journal 327, 933 (letter). McCormack J. & Greenhalgh T. (2000) Seeing what you want to see in randomised controlled trails: versions and perversions of UKPDS data. British Medical Journal 320, 1720– 1723. MRC/BHF (1999) Heart Protection Study Collaborative Group. Heart Protection Study of cholesterol lowering therapy and antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. European Heart Journal 20, 725– 741. MRC/BHF (2003) Heart Protection Study Collaborative Group. Heart Protection Study of cholesterol lowering with Simvastatin in 5963 people with diabetes: a randomised placebo controlled trial. Lancet 361, 2005– 2016. MRC/HF (2002) Heart Protection Study. http://www.ctsu.ox.ac.uk/~hps/slides/results/index.htm Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 344, 1383– 1389. UKPDS (1998) Intensive blood glucose control with sulphonylured or insuline compared with conventional treatment and risk of complications in patients with type II Diabetes (UKPDS 33). Lancet 352, 837– 852. Youssuf S. (2002) Commentary on HPS. Lancet 360, 2. Volume11, Issue4August 2005Pages 405-407 ReferencesRelatedInformation
Referência(s)